Tag : afraf

UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration

3 hours from now
Communiqué précisant les modalités de mise à disposition des Final Terms de l’émission de la BFCM séries 592 tranche 1

3 hours from now
UMH PROPERTIES, INC. WILL HOST THIRD QUARTER 2025 FINANCIAL RESULTS WEBCAST AND CONFERENCE CALL

3 hours from now
New Online Learning Option Launches for New Hampshire Students and Families

2 hours from now
King Copper Discovery Corp. Announces Closing of $15 Million Financing

2 hours from now